Jong Seok Lee

11.2k total citations · 4 hit papers
144 papers, 5.2k citations indexed

About

Jong Seok Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jong Seok Lee has authored 144 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 77 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Jong Seok Lee's work include Lung Cancer Treatments and Mutations (47 papers), Colorectal Cancer Treatments and Studies (24 papers) and Lung Cancer Research Studies (23 papers). Jong Seok Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (47 papers), Colorectal Cancer Treatments and Studies (24 papers) and Lung Cancer Research Studies (23 papers). Jong Seok Lee collaborates with scholars based in South Korea, United States and United Kingdom. Jong Seok Lee's co-authors include Jee Hyun Kim, Yu Jung Kim, Dae Seog Heo, Se Hyun Kim, Keun‐Wook Lee, Dong‐Wan Kim, Soo‐Mee Bang, Jeong‐Ok Lee, Seock‐Ah Im and Do‐Youn Oh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jong Seok Lee

137 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

2005 656 citations In Sil Choi, Jee Hyun Kim et al. profile →
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

2016 502 citations Jong Seok Lee, Ji‐Youn Han et al. profile →
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

2020 295 citations Lecia V. Sequist, Ji‐Youn Han et al. profile →
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTON

2022 95 citations Ryan J. Hartmaier, Aleksandra Markovets et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Jong Seok Lee

Since Specialization

Citations

This map shows the geographic impact of Jong Seok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Seok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Seok Lee more than expected).

Fields of papers citing papers by Jong Seok Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Seok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Seok Lee. The network helps show where Jong Seok Lee may publish in the future.

Co-authorship network of co-authors of Jong Seok Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Seok Lee. A scholar is included among the top collaborators of Jong Seok Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Seok Lee. Jong Seok Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence and outcome of pediatric moyamoya disease in the Republic of Korea: A nationwide study 2025 ·International Journal of Stroke ·(unknown), (unknown), Jong Seok Lee, Ji Hoon Phi, Ji Yeoun Lee, (unknown), Joong Shin Park, (unknown), Joongyub Lee, Seung‐Ki Kim	0
2	Individual domain characteristics determined by second-harmonic generation diffractometer for multi-domain multiferroics 2024 ·Scientific Reports ·Young Jin Jeong, (unknown), (unknown), (unknown), Chang Jae Roh, Jin Hong Lee, Chan‐Ho Yang, Jong Seok Lee	1
3	Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study 2024 ·Journal of Korean Medical Science ·Ji Yun Lee, Ju Hyun Lee, (unknown), Min-Su Kang, Eun Hee Jung, (unknown), Koung Jin Suh, Ji‐Won Kim, Se Hyun Kim, Jeong‐Ok Lee, Jin Won Kim, Yu Jung Kim, Keun‐Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo‐Mee Bang	1
4	Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer 2023 ·Thoracic Cancer ·(unknown), Changhoon Song, Kim Js, Jae Hyun Jeon, Sukki Cho, Kwhanmien Kim, Sanghoon Jheon, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee	5
5	Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study 2022 ·PLoS ONE ·Min-Su Kang, Koung Jin Suh, Ji‐Won Kim, Ja Min Byun, Jin Won Kim, Ji Yun Lee, Jeong‐Ok Lee, Soo‐Mee Bang, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Jong Seok Lee, Keun‐Wook Lee	3
6	Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTON breakdown → 2022 ·Cancer Discovery ·Ryan J. Hartmaier, Aleksandra Markovets, Myung‐Ju Ahn, Lecia V. Sequist, Ji‐Youn Han, Byoung Chul Cho, Helena A. Yu, Sang‐We Kim, James Chih‐Hsin Yang, Jong Seok Lee, Wu‐Chou Su, Dariusz M. Kowalski, С. В. Орлов, Song Ren, Paul Frewer, Xiaoling Ou, Darren A.E. Cross, Nisha Kurian, Mireille Cantarini, Pasi A. Jänne	95
7	Performance of clinician prediction of survival in oncology outpatients with advanced cancer 2022 ·PLoS ONE ·Yu Jung Kim, (unknown), Sang‐Yeon Suh, Yusuke Hiratsuka, Beodeul Kang, (unknown), Hong Yup Ahn, Koung Jin Suh, Ji‐Won Kim, Se Hyun Kim, Jin Won Kim, Keun‐Wook Lee, Jee Hyun Kim, Jong Seok Lee	7
8	The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors 2022 ·Thoracic Cancer ·(unknown), Se Hyun Kim, Eun Hee Jung, (unknown), Koung Jin Suh, Ji Yun Lee, Ji‐Won Kim, Jin Won Kim, (unknown), Yu Jung Kim, (unknown), Jee Hyun Kim, Soo‐Mee Bang, Jong Seok Lee	13
9	Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center 2022 ·JCO Oncology Practice ·Eun Hee Jung, (unknown), Yu Jung Kim, Beodeul Kang, Koung Jin Suh, Ju Hyun Lee, (unknown), (unknown), (unknown), Ji Yun Lee, Ji‐Won Kim, Se Hyun Kim, Jin Won Kim, Jeong‐Ok Lee, Keun‐Wook Lee, Jee Hyun Kim, Soo‐Mee Bang, Jong Seok Lee, Éduardo Bruera	8
10	Tumor LAG‐3 and NY‐ESO‐1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non‐small cell lung cancer 2021 ·Thoracic Cancer ·Eun Hee Jung, (unknown), Se Hyun Kim, Koung Jin Suh, Yu Jung Kim, Ju Hyun Lee, Jin‐Haeng Chung, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo, Jong Seok Lee	12
11	Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07 2020 ·Thoracic Cancer ·Miso Kim, Bhumsuk Keam, Chan‐Young Ock, Se Hyun Kim, Yu Jung Kim, Sun Min Lim, Jin‐Soo Kim, Tae Min Kim, Sook Hee Hong, Mi Sun Ahn, Seong Hoon Shin, Eun Joo Kang, Dong‐Wan Kim, (unknown), Jong‐Il Kim, Jong Seok Lee, Joo‐Hang Kim, Dae Seog Heo	19
12	Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer 2018 ·Yonsei Medical Journal ·(unknown), Se Hyun Kim, Yu Jung Kim, Joo Hyun Lee, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo, Jin-Haeng Chung, Yoon Kyung Jeon, Jong Seok Lee	7
13	Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study 2018 ·PLoS ONE ·In Sil Choi, (unknown), Ju Hyun Lee, Jee Hyun Kim, Koung Jin Suh, Ji Yun Lee, Beodeul Kang, Ji‐Won Kim, Se Hyun Kim, Jin Won Kim, Jeong‐Ok Lee, Yu Jung Kim, Soo‐Mee Bang, Jong Seok Lee, Keun‐Wook Lee	18
14	A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study 2018 ·PLoS ONE ·In Sil Choi, Jee Hyun Kim, Ju Hyun Lee, Koung Jin Suh, Ji Yun Lee, (unknown), Se Hyun Kim, Jin Won Kim, Jeong‐Ok Lee, Yu Jung Kim, Soo‐Mee Bang, Jong Seok Lee, Keun‐Wook Lee	8
15	BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression 2018 ·International Journal of Molecular Sciences ·Se Hyun Kim, (unknown), Chan-Young Ock, Koung Jin Suh, Ji Yun Lee, Ji‐Won Kim, Jeong‐Ok Lee, Jin Won Kim, Yu Jung Kim, Keun‐Wook Lee, Soo‐Mee Bang, Jee Hyun Kim, Jong Seok Lee, Joong Bae Ahn, Kui‐Jin Kim, Sun Young Rha	17
16	A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7 2015 ·PLoS ONE ·Jin Won Kim, Sehyun Kim, (unknown), Keun‐Wook Lee, Kwang‐Il Kim, Jong Seok Lee, Cheol‐Ho Kim, Jee Hyun Kim, (unknown)	13
17	Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey 2014 ·Journal of Korean Medical Science ·Jeong‐Ok Lee, Ju Hyun Lee, Soyeon Ahn, Jin Won Kim, Hyun Chang, Yu Jung Kim, Keun‐Wook Lee, Jee Hyun Kim, Soo‐Mee Bang, Jong Seok Lee	53
18	Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer 2014 ·World Journal of Surgical Oncology ·Miso Kim, Hyun Chang, Hee Chul Yang, Yu Jung Kim, Choon‐Taek Lee, Jae‐Ho Lee, Sanghoon Jheon, Kwhanmien Kim, Jin‐Haeng Chung, Jong Seok Lee	32
19	Environmental Factor on the Succession of Phytoplankton Community in Jinju Bay, Korea 2008 ·Journal of the Korean Society for Marine Environment & Energy ·Seok Jin Oh, Jong Seok Lee, (unknown), (unknown), Yang Ho Yoon	3
20	High-dose Cytarabine, Etoposide and Cisplatin Salvage Chemotherapy for Relapsed Adult Acute Myeloid Leukemia. 2004 ·The Korean Journal of Hematology ·Jong Seok Lee, (unknown), Kyungwon Lee, Won Sup Lee, Jung Hun Kang, (unknown), Jihyun Kim, Sung Soo Yoon, (unknown), Byoung Kook Kim	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact